Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2019-08-07 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-08-07 English
FORM 4
Director's Dealing
2019-08-07 English
SC TO-T/A Filing
M&A Activity Classification · 100% confidence The document is a Schedule TO filing with the SEC, which is a Tender Offer Statement under the Securities Exchange Act of 1934. It relates to a tender offer by Medpace Investors, LLC and August J. Troendle to purchase vested stock options from employees of Medpace Holdings, Inc. The document includes detailed information about the tender offer terms, parties involved, securities ownership, and related agreements. It is not an annual report, earnings release, or other financial report but a regulatory filing specific to a tender offer transaction. The presence of terms like 'Schedule TO', 'Tender Offer Statement', and detailed transaction terms confirms this is a filing related to a tender offer. According to the filing definitions, this corresponds to M&A Activity (Code: TAR) as it relates to merger proposals or takeover bids, including tender offers. The document is substantive and not merely an announcement or certification, so it is not classified as RNS or RPA. Therefore, the correct classification is TAR with high confidence.
2019-08-07 English
SC TO-I
Major Shareholding Notification
2019-08-05 English
10-Q
Interim / Quarterly Report Q2 2019
2019-07-30 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated July 29, 2019, from Medpace Holdings, Inc. It announces the issuance of a press release with financial results for the three and six months ended June 30, 2019. The text states that the press release is furnished as an exhibit and posted on the company's website. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a notification of the earnings release. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights, even though the full details are in the press release exhibit and on the website. The document length is under 5,000 characters but it is not merely announcing the publication of a report; it is the actual earnings release filing (8-K) announcing results. Therefore, the appropriate classification is ER with high confidence.
2019-07-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.